* MedAvail Holdings Inc MDVL.OQ MDVL.O is expected
to show a
rise in quarterly revenue when it reports results on March 30.
* The Phoenix Arizona-based company is expected to report
a
51.0% increase in revenue to $10.995 million from $7.28 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for MedAvail Holdings
Inc is
for a loss of 15 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MedAvail
Holdings
Inc is $2.5, above its last closing price of $0.26.
This summary was machine generated March 28 at 21:59 GMT. All
figures in US dollars unless otherwise stated